Randomized, controlled clinical trial of glargine insulin versus ultralente insulin in type 1 diabetes

被引：0
|
作者：
Kudva, Y
Basu, A
Jenkins, G
Pons, G
Quandt, L
Gebel, J
Vogelsang, D
Smith, S
Isley, W
Rizza, R
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A133 / A133
页数：1
相关论文
共 50 条
  • [21] Insulin Analogues Insulin Glargine and Insulin Glulisine in Type 1 Diabetes
    Schreiber, S. A.
    Fiesselmann, A.
    Bornstein, S. R.
    Landgraf, W.
    DIABETES STOFFWECHSEL UND HERZ, 2011, 20 (02): : 69 - 77
  • [22] Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial
    Dashora, U. K.
    Sibal, L.
    Ashwell, S. G.
    Home, P. D.
    DIABETIC MEDICINE, 2007, 24 (04) : 344 - 349
  • [23] Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial
    Home, Philip D.
    Lam, Raymond L. H.
    Carofano, Wendy L.
    Golm, Gregory T.
    Eldor, Roy
    Crutchlow, Michael F.
    Marcos, Michael C.
    Rosenstock, Julio
    Hollander, Priscilla A.
    Gallwitz, Baptist
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2220 - 2228
  • [24] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Swinnen, Sanne G.
    Simon, Airin C. R.
    Holleman, Frits
    Hoekstra, Joost B.
    DeVries, J. Hans
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [25] Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial
    Bell, Kirstine J.
    Gray, Robyn
    Munns, Diane
    Petocz, Peter
    Steil, Garry
    Howard, Gabrielle
    Colagiuri, Stephen
    Brand-Miller, Jennie C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (04) : 218 - 225
  • [26] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Simon, A. C. R.
    Swinnen, S. G.
    Holleman, F.
    Hoekstra, J. B. L.
    DeVries, J. H.
    DIABETOLOGIA, 2011, 54 : S420 - S421
  • [27] Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes The SWITCH 1 Randomized Clinical Trial
    Lane, Wendy
    Bailey, Timothy S.
    Gerety, Gregg
    Gumprecht, Janusz
    Philis-Tsimikas, Athena
    Hansen, Charlotte Thim
    Nielsen, Thor S. S.
    Warren, Mark
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (01): : 33 - 44
  • [28] Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes: A phase III, randomized, controlled trial
    Yan, Xiang
    Jiang, Shan
    Lou, Ying
    Zhou, Zhiguang
    DIABETES OBESITY & METABOLISM, 2021, 23 (10): : 2226 - 2233
  • [29] A randomized crossover trial comparing insulin glargine plus insulin lispro with NPH insulin plus soluable insulin in adolescents with Type 1 diabetes.
    Murphy, N
    Keane, S
    Ong, K
    Ford-Adams, M
    Edge, J
    Dunger, D
    DIABETOLOGIA, 2002, 45 : A281 - A281
  • [30] Latin American clinical trial project on insulin glargine versus NPH insulin plus glimepiride in Type 2 diabetes.
    Eliaschewitz, FG
    Calvo, C
    Valbuena, H
    Ruiz, M
    Aschner, P
    Villena, J
    Ramirez, LA
    Jimenez, J
    Macêdo, M
    DIABETOLOGIA, 2003, 46 : A272 - A272
12345